Calprotectin Test Kit

The Biohit Calprotectin ELISA enables the non-invasive and cost-effective differentiation between irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD) using a stool sample. The concentration of fecal calprotectin increases significantly in organic disorders such as IBD, while this does not occur in functional disorders like IBS.

The mucosal healing of a patient with IBD can also be monitored using the Biohit Calprotectin ELISA. For instance, this assists the practitioner in making well-informed decisions regarding the necessity of medical procedures, such as surgery or endoscopy.

Applications

Distinguishes between inflammatory bowel diseases (IBD) and irritable bowel syndrome (IBS)
IBD patients’ mucosal healing monitoringRelapse prediction (clinical remission)
Sampling simplifiedThe outcome is not influenced by the consistency of the feces.A minimal quantity of sample is necessary.
Hygienic extraction tubes facilitate effortless handling, thereby decreasing the duration of the process.Uncomplicated examinationA broad assay range is achievable with a single dilution of 25–2500 mg/kg in feces.Fits seamlessly into automated systems (e.g., Dynex DS2)

Validated results from a proven assayinput:
output:For optimal analytical performance, it is strongly advised to utilize Biohit Extraction Tubes (Cat. No. 602 270).input:
output:Please be advised that:In certain countries, the availability is restricted. For additional information, please reach out to us at info (at) biohit.fi.

For research purposes only in the United States and Japan. Please consult your regional Biohit distributor for information regarding other countries.input:
output:The Biohit Calprotectin ELISA is a quantitative test that reliably distinguishes between irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD).